Medical Groups Urge Reexamination of Broad Approval of Abortion Drugs

Pro-life medical groups are urging Health Secretary Xavier Becerra and the FDA to reexamine the broad approval of abortion drugs under the Trump administration, citing concerns about patient safety and potential misuse of these medications. The move comes as Planned Parenthood sues the Trump administration over provisions in the 'big, beautiful bill' that would defund abortion providers. Medical groups are calling for a more nuanced approach to regulating abortion medication, one that prioritizes both access to safe care and protection from improper use. They argue that FDA approval of these medications was overly broad, allowing for too much flexibility in their prescribing and dispensing.